Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
62%
Overall Survival
61%
Stereotactic Body Radiation Therapy
56%
Malignant Neoplasm
45%
Intensity Modulated Radiation Therapy
34%
Disease
32%
Pancreas Cancer
32%
Treatment Planning
29%
Prostate Cancer
23%
Non Small Cell Lung Cancer
23%
Chemoradiotherapy
22%
Surgery
22%
Brain Metastasis
20%
Breast Cancer
17%
Recurrent Disease
17%
Metastatic Carcinoma
17%
Tumor Cell
17%
Radiomics
16%
Radiation Oncology
15%
Stereotactic Radiosurgery
14%
Cancer Cell
13%
Non-Hodgkin Lymphoma
13%
Stem Cell
13%
Oncology
13%
Lung Cancer
12%
Drug Megadose
11%
Pancreas Adenocarcinoma
11%
Base
11%
Immunotherapy
11%
Dose Calculation
11%
Head and Neck Cancer
10%
Pediatrics
10%
Squamous Cell Carcinoma
9%
Adjuvant Chemotherapy
9%
In Vitro
9%
Dosimetry
9%
Radiosensitivity
9%
Rectum Cancer
9%
Surveillance, Epidemiology, and End Results
9%
Hazard Ratio
9%
Esophageal Cancer
8%
Adjuvant Therapy
8%
Brachytherapy
8%
Nasopharynx Cancer
8%
Proton Therapy
8%
Isocenter
8%
Proportional Hazards Model
8%
Multivariate Analysis
7%
Survival Rate
7%
Mononuclear Cell
7%
External Beam Radiotherapy
7%
Primary Tumor
7%
Bladder
7%
Cancer Therapy
7%
Magnetic Resonance Imaging
7%
Cytokine
7%
Lymphoma Cell
7%
Disease Free Survival
7%
Monitor Unit
6%
Endometrial Cancer
6%
Prostatectomy
6%
Systemic Therapy
6%
Radiology
6%
Kaplan Meier Method
6%
Prognostic Factor
6%
Urogastrone
6%
Stereotactic Radiotherapy
6%
Patient Positioning
6%
Breathing
6%
Organ Motion
6%
Morphology
6%
Cell Population
6%
Chemoradiation Therapy
6%
Anal Cancer
6%
Neoadjuvant Therapy
6%
High Dose Chemotherapy
5%
Radiation Pneumonia
5%
Medicare
5%
Logistic Regression Analysis
5%
Adenocarcinoma
5%
Hematopoietic Stem Cell
5%
Tumor Progression
5%
Apheresis
5%
Frameless Stereotactic Procedure
5%
Whole Brain Radiotherapy
5%
Clinical Trial
5%
Image-Guided Intervention
5%
Keyphrases
Overall Survival
25%
Radiation Therapy
21%
Chemotherapy
12%
National Cancer Database
11%
Early-stage Lung Cancer
11%
Cell Manufacturing
11%
Brain Metastases
10%
Tumor
10%
Stereotactic Body Radiation Therapy
10%
Bone Marrow
9%
Intestinal Regeneration
8%
Stereotactic Body Radiotherapy
8%
Non-Hodgkin Lymphoma
7%
Adjuvant Chemotherapy
7%
Pancreatic Ductal Adenocarcinoma
6%
Chemoradiotherapy
6%
Irradiation
6%
ACR Appropriateness Criteria
6%
Radiotherapy
6%
Hazard Ratio
6%
Tumor Cells
6%
Culture Method
5%
Medulloblastoma
5%
Cancer Cells
5%
Chemoradiation
5%
125I
5%
Hematopoietic Stem Cells
5%
Marrow
5%